Zusammenfassung
Mit dem Wechsel in das neue Jahrtausend ist es 35 Jahre nach der Erstbeschreibung des ARDS („adult respiratory distress syndrome“), das die Extremform einer akuten respiratorischen Insuffizienz darstellt, erstmals gelungen die Sterblichkeit in einer multizentrischen, kontrollierten Studie an 861 Patienten um 22% zu senken (ARDS-Network Study 2000). Die herausragende Bedeutung dieser Untersuchung muss vor dem Hintergrund gesehen werden, dass über 35 Jahre eine Vielzahl von Therapieanstrengungen unternommen worden waren, die bislang alle keinen Vorteil für das Überleben der Patienten mit ARDS erbracht hatten. Dieser Erfolg wurde jedoch nicht durch Einsatz neuer komplizierter oder raffinierter Pharmaka erzielt, sondern lediglich durch die Begrenzung des Atemzugvolumens auf 6 ml/kgKG gegenüber 12 ml/kgKG.
Im Rückschluss müssen wir aus dieser Studie aber auch lernen, dass die Beatmung schädigen und die Prognose der von uns beatmeten Patienten negativ beeinflussen kann. Der Stellenwert der invasiven Beatmung zur Überbrückung akuter lebensbedrohlicher hypoxämischer Zustände gilt nach wie vor als unumstritten, unterschiedliche Beatmungsstrategien können aber mit einer signifikanten Reduktion der Letalität einher gehen. Mit dem Wissen um die „iatrogene“ Schädigung der Lunge unter der Beatmung ist es naheliegend, den Stellenwert der nichtinvasiven Beatmung, neben seiner Bedeutung für die chronisch obstruktiven Lungenerkrankungen, auch für das hypoxämische Lungenversagen nicht als Alternative sondern als ergänzende Therapieoption zur konventionellen Beatmung zu diskutieren. Für die nichtinvasive Beatmung bei COPD-Patienten belegte eine Metaanalyse (Keenan et al. 1997) eindeutig einen Überlebensvorteil. Eine neue multizentrische, kontrollierte Studie (Plant et al. 2000) bei 236 COPD-Patienten erzielte sogar eine Senkung der Letalität durch die Ergänzung der Standardtherapie mit nichtinvasiver Beatmung um 50%.
Zusammenfassend zeigen diese Untersuchungen, dass der Beatmung als Therapie eine entscheidende Bedeutung zufällt und „Indikationen, Dosis, Nebenwirkungen etc.“ wie bei allen übrigen Therapieformen ebenfalls beherrscht werden müssen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Acute Respiratory Distress Syndrome (ARDS) Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
Amato MBP, Barbas CSV, Medeiros DM et al. (1995) Beneficial effects of the „open lung approach“ with low distending pressures in acute respiratory distress syndrome: a prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 1835–1846
Amato MBP, Barbas CSV, Medeiros DM et al. (1998) Effect of a protective ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338:347–354
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet II:319–323
Bernard GR, Artigas A, Brigham KL et al. and the Consensus Committee (1994) The American-European Consensus conference on ARDS. Am J Respir Crit Care Med 149:818–824
Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1989a) Sepsis Syndrome: A Valid Clinical Entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med 17:389–393
Bone RC, Slotman G, Maunder R, Silvermann H, Ursprung JJ (1989b) Randomized Double-Blind, Multicenter Study of Prostaglandin E1 in patients with the adult respiratory distress syndrome. Chest 96: 114–119
Brochard L, Roudot-Thoraval F, Roupe E Collaborative group on VT reduction (1998) Tidal volume reduction for prevention of ventiolator-induced lung injury in acute respiratory distress syndrome (ARDS): a multicenter randomized study. Am J Respir Crit Care Med 158:1831–1838
Dellinger RP, Zimmermann JL, Taylor RW et al. and The Inhaled Nitric Oxide in ARDS Study Group (1998) Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Crit Care Med 26:15–23
Driks MR, Craven CE, Cell BR et al. (1987) Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med 317: 1376–1382
Ely EW, Baker AM, Dunagan DP et al. (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 335:1864–1869
Farmer JC, Burkey ThH, Kew RR, Webster RO (1991) Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro. Am Rev Respir Dis 144:593–599
Ferguson GT, Gilmartin M (1995) CO2 rebreathing during BiPAP ventilatory assistance. Am J Respir Crit Care Med 151:1126–1135
Frostell C, Fratacci M-D, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038–2047
Gagnon S, Boota AM, Fischl MA (1990) Corticosteroids as adjunctive therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323:1440–1450
Gallart L, Lu Q, Puybasset L et al. and the NO Almitrine Study Group (1998) Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. Am J Respir Crit Care Med 158:1770–1777
Gattinoni L, Pelosi P, Vitale G, Pesenti A, D’Andrea L, Mascheroni D (1991) Body positive changes redistribute lung computed-tomographie density in patients with acute respiratory failure. Anesthesiol 74:15–23
Gattinoni L, Tognoni G, Pesenti A et al. and the Prone-Supine Study Group (2001) Effect of Prone Positioning on the Survival of Patients with Acute Respiratory Failure. N Engl J Med 345:568–573
Gregory TJ, Steinberg KP, Spragg R et al. (1997) Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155:1309–1315
Grimminger F, Seeger W (1990) Regulation inflammatorischer Abläufe — Angriffspunkte und Grenzen steroidaler Antiphlogistika. Medwelt 41:951–964
Günther A, Siebert C, Schmidt R et al. (1996) Surfactant alterations in severe pneumonia, ARDS, and cardiogenic lung edema. Am J Respir Crit Care Med 153:176–184
Hickling KG, Henderson SJ, Jackson R (1990) Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intens Care Med 16:372–377
Hickling KG, Walsh J, Henderson S, Jackson R (1994) Low mortality rate in adult respiratory distress syndrome using low volume, pressure limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 22:1568–1578
High KM, Snider MT, Richard R, Russell GB et al. (1992) Clinical trials of an intravenous oxygenator in patients with adult respiratory distress syndrome. Anesthesiology 77:856–863
Holcroft JW, Vassar MJ, Weber CJ (1986) Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. Ann Surg 203:371–378
Hudson LD (1998) Protective ventilation for patients with acute respiratory distress syndrome. N Engl J Med 338:385–387
Inglis TJJ, Sherratt MJ, Sproat LJ, Gibson JS, Hawkey PM (1993) Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung. Lancet 341:911–913
Jenkinson S (1989) Prostaglandin E1: not the magic bullet in ARDS. Chest 96:1–2
Keenan SP, Kernerman PD, Cook DJ, Martin CM, McCormack D, Sibbald WJ (1997) Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med 25:1685–1692
Langer M, Mascheroni D, Marcolin R, Gattinoni L (1988) The Prone Position in ARDS Patients. Chest 94:103–107
Lasch HG, Lenz L, Seeger W (Hrsg) (1997) Lehrbuch der Internistischen Intensivtherapie, 3. Aufl. Schattauer, Stuttgart
Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C for The European Study Group of Inhaled Nitric Oxide (1999) Inhalation of nitric oxide in acute lung injury: results of a european multicenter study. Intensive Care Med 25:911–919
Masip J, Betbesé AJ, Páez J et al. (2000) Non-invasive pressure support ventilation vs. conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 356: 2126–2132
Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, El Torky M, Leeper KV Jr (1991) Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 100:943–952
Milberg JA, Davis DR, Steinberg KP, Hudson LD (1995) Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983–1993. JAMA 273(4):306–309
Morris AH, Wallace CJ, Menlove RL, Clemmer TP et al. (1994) Randomized clinicl trial of pressure controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149:295–305
Mustard RA, Bohnen JMA, Rosati C, Schouten D (1991) Pneumonia complicating abdominal sepsis. An independent risk for mortality. Arch Surg 126:170–175
National Heart, Lung, and Blood Institute (NHLBI) (1979) Extracorporeal Support for Respiratory Insufficiency. In: Division of Lung (ed) Diseases. A Collaborative Study in Response to RFP-NHLI-73-20
Nava S, Evangelisti I, Rampulla C, Compagnoni ML, Fracchia C, Rubini F (1997) Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure. Chest 111:1631–1638
Pang D, Keenan SP, Cook DJ, Sibbald WJ (1998) The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema. Chest 114:1185–1192
Plant PK, Owen JL, Elliott MW (2000) Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards:a multicentre randomised controlled trial. Lancet 355:1931–1935
Prost JF, Desché P, Jardin F, Margairaz A (1991) Comparison of the effects of intravenous almitrine and positive end-exspiratory pressure on pulmonary gas exchange in adult respiratory distress syndrome. Eur Respir J 4:683–687
Puybasset L, Rouby JJ, Mourgeon E, Stewart TE et al. (1994) Inhaled nitric oxide in acute respiratory failure: dose-response curves. Int Care Med 20:319–327
Radermacher P, Santak B, Becker H, Falke KJ (1989) Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 70:601–606
Radermacher P, Santak B, Wüst HJ, Tarnow J, Falke KJ (1990) Prostacyclin and right ventricular functions in patients with pulmonary hypertension associated with ARDS. Intens Care Med 16: 227–232
Reinhart K, Hannemann L, Kuss B (1990) Optimal oxygen delivery in critically ill patients. Intens Care Med 16:149–155
Reyes A, Roca J, Rodriguez-Roisin R, Torres A, Ussetti P, Wagner PD (1988) Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am Rev Respir Dis 137: 1062–1067
Rossaint R, Lopez S, Falke KJ, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399–405
Russell JA, Ronco JJ, Dodek PM (1990) Physiologic effects and side effects of prostaglandin E1 in the adult respiratory distress syndrome. Chest 97:684–692
Russell JA, Phang PT (1994) The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am J Respir Crit Care Med 149:533–537
Schönhofer B, Köhler D (1995) Atemregulation und Kompensationsmechanismus bei ventilatorischer Insuffizienz. Internist 36:769–780
Schuller D, Mitchell JP, Calandrino FS, Schuster DP (1991) Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest 100:1068–1075
Seeger W, Neuhof H, Hall J, Roka L (1988) Pulmonary vasoconstrictor response to soluble fibrin in isolated lungs: possible role of thromboxane generation. Circ Res 62:651–659
Shoemaker WC, Appel PL (1986) Effects of prostaglandin E1 in adult respiratory distress syndrome. Surgery 99:275–282
Slotman GJ, Burchard KW, D’Arezzo A et al. (1988) Ketaconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma 28:648–654
Slutsky AS (1994) Consensus conference on mechanical ventilation January 28–30, 1993 at Northbrook, Illinois, USA. Part I. Intensive Care Med 150:1722–37
Snider GL (1988) ARDS, neutrophils and pentoxifylline. Am Rev Respir Dis 138:1103–1105
Stewart TE, Meade MO, Cook DJ (1998) Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med 338:355–361
Sznajder JI, Wood LDH (1991) Beneficial effects of reducing pulmonary edema in patients with acute hypoxemic respiratory failure. Chest 100:890–891
Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Kelly KM, Smith TC, Small RJ (2004) Low-dose inhaled nitric oxide in patients with acute lung injury — randomized controlled trial. JAMA 291:1603–1631
Tomasa G (1993) A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 21:1635–1642
Van Saene HKF, Stoutenbeek CC, Stoller JK (1992) Selective decontamination of the digestive tract in the intensive care unit: current status and future prospects. Crit Care Med 20:691–703
Villar J, Slutsky AS (1989) The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis 140:814–816
Vincent JL (1990) The relationship between oxygen demand, oxygen uptake, and oxygen supply. Intens Care Med 16:145–148
Vincent JL, Roman A, de Backer D, Kahn RJ (1990) Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion. Am Rev Respir Dis 142:2–7
Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1993) Aerolised prostacyclin reduces pulmonary artery pressure and improves gas exchange in the adult respiratory distress syndrome (ARDS). Lancet 342:961–962
Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1995) Aerosolized prostacyclin in patients with severe pneumonia in the absence and presence of fibrosis. Am J Respir Crit Care Med 151:724–730
Walmrath D, Schermuly R, Schneider T, Olschewski H, Grimminger F, Seeger W (1996a) Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in ARDS. Am J Respir Crit Care Med 153: 991–996
Walmrath D, Günther A, Ghofrani HA, Schermuly R, Schneider T, Grimminger F, Seeger W (1996b) Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome (ARDS) and sepsis. Am J Respir Crit Care Med 154:57–62
Yu M, Tomasa G (1993) A double-blind, prospective, randomized trial of ketaconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 21:1635–1642
Zapol WM, Riman S, Gillis N, Marletta M, Bosken CH (1994) Nitric oxide and the lung. Am J Respir Crit Care Med 149:1375–1380
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag
About this chapter
Cite this chapter
Walmrath, D., Grimminger, F., Seeger, W. (2005). Akute und chronische respiratorische Insuffizienz. In: Steinbeck, G., et al. Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26504-X_26
Download citation
DOI: https://doi.org/10.1007/3-540-26504-X_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23750-1
Online ISBN: 978-3-540-26504-7
eBook Packages: Medicine (German Language)